title: The optimal treatment of STEMI: new pharmacological and device approaches.
abstract: Cardiovascular disease remains the leading cause of mortality worldwide. Many deaths are contributed to acute ST elevation myocardial infarction (STEMI). Recently, epidemiological studies have been shown reduction in STEMI related mortality over the last decade. This reduction has partially been attributed to new pharmacological and device advances that were utilized during STEMI treatment. The goal of this manuscript is to review new pharmacological and device approaches available in the treatment of STEMI patients.
authors.affiliation: CareMore Health Care Arizona, Division of Cardiology The Southern Arizona VA health Care System Tucson, Arizona and Division of Cardiology University of Arizona, Tucson, AZ, USA - rmova@aol.com.
authors.forename: M R
authors.initials: MR
authors.lastname: Movahed
mesh_terms: D020341:Absorbable Implants; D062906:Cardiac Catheters / Q000639:trends; D002317:Cardiovascular Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004059:Diffusion of Innovation; D054855:Drug-Eluting Stents; D006801:Humans; D009203:Myocardial Infarction / Q000175:diagnosis / Q000401:mortality / Q000628:therapy*; D062645:Percutaneous Coronary Intervention / Q000009:adverse effects / Q000295:instrumentation* / Q000401:mortality / Q000639:trends; D011474:Prosthesis Design; D015607:Stents / Q000639:trends; D017131:Thrombectomy / Q000009:adverse effects / Q000295:instrumentation* / Q000401:mortality / Q000639:trends; D016896:Treatment Outcome
chemical_list: D002317:Cardiovascular Agents